Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Ifeanyichukwu Ifechidere: What Do You Understand about Anticoagulant Interference in Coagulation Tests?
Ifeanyichukwu Ifechidere/LinkedIn
Mar 23, 2026, 15:45

Ifeanyichukwu Ifechidere: What Do You Understand about Anticoagulant Interference in Coagulation Tests?

Ifeanyichukwu Ifechidere, Biomedical Scientist at Sheffield Teaching Hospitals NHS Foundation Trust, shared a post on LinkedIn:

“What Do You Understand About Anticoagulant Interference in Coagulation Tests?

One of the most common – and most misinterpreted – causes of abnormal coagulation results is anticoagulant interference.

Before diagnosing a factor deficiency or inhibitor, we must always ask:

Is this a true coagulopathy – or drug effect?

Failure to recognize anticoagulant interference leads to:

  • Unnecessary factor assays
  • Misdiagnosis
  • Delayed procedures
  • Incorrect clinical decisions

Let’s break it down clearly.

1. Heparin (UFH)

Most affected test: APTT

APTT: Prolonged

PT: Normal or mildly prolonged

Thrombin Time (TT): Markedly prolonged

Clue: Prolonged TT that corrects with heparin neutralization.

2. Low Molecular Weight Heparin (LMWH)

APTT: Often normal

Anti-Xa assay required for monitoring

Important: A normal APTT does NOT exclude LMWH effect.

3. Direct Oral Anticoagulants (DOACs)

These are increasingly common and frequently confuse interpretation.

  • Direct Thrombin Inhibitors (e.g., dabigatran)

APTT: Prolonged

TT: Very sensitive (markedly prolonged)

  • Direct Factor Xa Inhibitors (e.g., rivaroxaban, apixaban)

PT: May be prolonged (reagent-dependent)

APTT: Variable

Anti-Xa (drug-specific) assay preferred

Key issue: Routine PT/APTT cannot reliably quantify DOAC effect.

4. Warfarin

PT/INR: Prolonged

APTT: May be mildly prolonged

Classic isolated prolonged PT pattern.

Why This Matters in the Laboratory

Anticoagulant interference can mimic:

  • Factor deficiencies
  • Liver disease
  • DIC
  • Inhibitors

Without medication history, interpretation becomes guesswork.

Practical Laboratory Approach

Before escalating to mixing studies or factor assays:

  • Confirm medication history
  • Consider timing of last dose
  • Review thrombin time
  • Use drug-specific assays when indicated
  • Communicate with clinicians

Take-Home Message

Not every prolonged PT or APTT indicates pathology.

Sometimes, it simply reflects pharmacology.

Interpretation without clinical context is incomplete.”

Ifeanyichukwu Ifechidere

Stay updated with Hemostasis Today.

Anticoagulant Interference Direct Oral Anticoagulants DOACs Health Hematology Hemostasis Hemostasis News Hemostasis Today Heparin Ifeanyichukwu Ifechidere LMWH Low-Molecular-Weight Heparin Medicine UFH Warfarin
NewsFeed